Skip to main content

ALL ABOUT MS Treatment (Part 8)

By
Treatment

Since research has shown that MS is an autoimmune disease, two basic approaches, immunosuppression (weakening of the immune response of the organism) and immunomodulation (changing the immune response) are used in the treatment.
Numerous studies have shown that in the treatment of MS, the following drugs have success: interferon beta (betaferon, rebif, avonex), glatiramer acetate (copaxone), natalizumab (tysabri), mitoxantrone (novantrone) and some other cytostatics.


Interferon beta
Interferon beta is a protein that is a natural component of the human organism and is created by the cells of our immune system during defense reactions to external agents, primarily viruses. However, the most important effect this protein has is the so-called. Immunomodulatory effect: interferon beta promotes processes that mitigate the effects and slow down the ankle of multiple sclerosis, while the opposite inhibits it. The exact mechanism by which the interferon beta acts therapeutically in MS is not known.

The recombinant interferon beta is a synthetic interferon beta obtained by genetic engineering and which is identical in nature or very similar to natural interferon. The process of producing this drug is very complicated and expensive, which is why the price of this medicine is high.

There are two types of recombinant interferon beta: interferon beta 1b (Betaferon) and interferon beta1a (Rebif and Avonex).

Interferon beta is not a cure that can cure MS, but can reduce the number of exacerbations of the disease by 30%, reduce the severity of disease worsening by 50%, significantly prolong the period when the disease stays (remission), significantly slow down the creation of new changes in magnetic resonance Brain and slow down the process of brain mass loss (brain atrophy).

The broadest therapeutic area has Betaferon that can be used in people after the first clinical indication suggesting multiple sclerosis, in people with relapse-reactive disease, and in people with a secondary-progressive form of the disease.

Betaferon is administered in a dose of 8 million international units (MIJ) every other day, in the form of subcutaneous injections (subcutaneous).

Rebif is administered at a dose of 6 or 12 MIJ, three times a week, also in the form of subcutaneous injections.

Avonex is given once a week at a dose of 6 MJ, intramuscularly.
The best effects have been shown to have high doses of interferon that are more commonly administered (Betaferon, Rebif).

The experience of more than 10 years of interferon beta administration has shown that the drug is completely safe and that the side effects that occur in most patients are mild and transient, but it is essential that the patient be informed of how to overcome them. The most common side effects are fever-like conditions (fever, trembling, smallness, muscle and joint pain) that occur several hours after administration of the drug and may last for several hours, changes in the injection site (redness, islet, pain), transient deterioration in neurological condition, changes in laboratory findings (elevation of liver enzymes, decrease in leukocytes and anemia), menstrual cycle disorders, more depression, skin rash and allergic reaction.

A situation similar to that of the flu usually occurs at the beginning of therapy, and it is recommended that treatment with low doses of interferon beta be started with analgesics for 4 hours before, at the time and 4 hours after administration. Aspirin and non-steroidal anti-inflammatory drugs (ibuprofen) are recommended from analgesics. The local reaction at the site of interferon beta administration is best alleviated by changing the site of the application and the drug is taken warm at room temperature.
Medication should not be used in pregnancy if there is hypersensitivity to interferon beta or human albumin in patients with severe depressive disorders or suicidal attempts in patients with severe hepatic impairment and in patients with poorly controlled epilepsy.
Training patients for preparation and self-administration as well as counseling on treating adverse effects of therapy are carried out in specialized centers for the fight against multiple sclerosis.

In the event of a worsening of the disease, pulse therapy with methylprednisolone (Lemod-Solu) is applied, and interferon beta therapy is not interrupted.
Interferon beta therapy is long-standing and should not be started or discontinued without consulting with the doctor.
Labels:

Comments

Post a Comment

Popular posts from this blog

My FEELING, My train of THOUGHT (Part 1)

By
My FEELING, My train of THOUGHT Inspired by thoughts, I am created this my short text, which is engraved in my mind!   Certainly, things like this in  future time will be a lot more!  These short texts best describe our feelings, so read carefully and with .... Just READ The direction of the eye So wrong Avoiding the soul So missing I'm not asking Our existence Just asking Why am I in a war with my hands? Why am I in a war with my feet? Why am I in the war with me? And after all, I'm still going I'm not showing I do not share I do not need it What you have to give, GIVE!
1 comment
Read more

LIVES WITH MS - Wellness

By
LIVES WITH MS - Wellness Wellness is a dynamic state of physical, emotional, spiritual and social well-being that can be achieved even in the presence of chronic illness or disability. For people living with MS, the path to wellness involves more than the treatment of the disease. Equally important are the promotion of health and prevention strategies, satisfaction of personal relationships, strong network of support, fulfillment in work and rest, a significant place in the community, and special attention dedicated to your inner being. Family members and caregivers should also pay attention to their own health and well-being. In order to provide the best possible care and support to others, it is important that their own needs are met. Make your way to Wellnes In addition to being essential for general health and well-being, the exercise is useful in managing symptoms of MS. The study, published by researchers at the University of Utah in 1996, was the first to cl...
Post a Comment
Read more

ALL ABOUT MS Treatment (Part 11)

By
Treatment of relapse and some symptoms Routine therapy for acute relapses is an intravenous high dose of corticosteroids, usually methylprednisolone at a dose of 500 to 1000 mg daily for three to five days. The aim of this therapy is to stop the attack as soon as possible in order to keep as little a consequence of this attack. Although generally effective in short-term symptom relief, corticosteroids do not have a significant impact on long-term recovery. In addition, longer therapy with corticosteroids can lead to osteoporosis, high blood pressure, psychotic reactions, convulsions, and cataracts. Spasticity, which can be manifested as a permanent contraction caused by an increased muscle tone or transient spasm, is usually treated with muscle relaxants and mitralants such as baclofen, tizanidine, diazepam, clonazepam, and dantrolene. Physical therapy and exercises help preserve existing functions, while various aids, such as a walkway, a stick and a prosthesis, serve to k...
Post a Comment
Read more